1. 1) Sasaki, K.; Yonebayashi, S.; Yoshida, M.; Shimizu, K.; Aotsuka, T.; Takayama, K. Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. Int. J. Pharm. 265, 95-102 (2003).
2. 2) Higaki, K.; Yata, T.; Sone, M.; Ogawara, K.-I.; Kimura, T. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine. Res. Commun. Mol. Pathol. Pharmacol. 109, 231-240 (2001).
3. 3) Shibata, N.; Ohno, T.; Shimokawa, T.; Hu, Z.; Yoshikawa, Y.; Koga, K.; Murakami, M.; Takada, K. Application of pressure-controlled colon delivery capsule to oral administration of glycyrrhizin in dogs. J. Pharm. Pharmacol. 53, 441-447 (2001).
4. 4) Koga, K.; Kawamura, M.; Iwase, H.; Yoshikawa N. Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in rats. Drug Des. Devel. Ther. 7, 1235-1243 (2013).
5. 5) Terech, P.; Friol, S. Rheometry of an androstanol steroid derivative paramagnetic organogel. Methodology for a comparison with a fatty acid organogel. Tetrahedron 63, 7366-7374 (2007).